Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28981086)

Published in Cell Death Dis on October 05, 2017

Authors

Gloria Alvarez-Sola1, Iker Uriarte1, Maria U Latasa2, Maddalen Jimenez2, Marina Barcena-Varela2, Eva Santamaría1, Raquel Urtasun2, Carlos Rodriguez-Ortigosa1,2, Jesús Prieto1,2, Fernando J Corrales2,3, Anna Baulies3,4,5, Carmen García-Ruiz3,4,5, Jose C Fernandez-Checa3,4,5, Pedro Berraondo6, Maite G Fernandez-Barrena1,2, Carmen Berasain1,2, Matías A Avila1,2

Author Affiliations

1: CIBERehd, Instituto de Salud Carlos III, Clinica Universidad de Navarra, Avda, Pio XII, n 36, Pamplona 31008, Spain.
2: Hepatology Programme, CIMA, Idisna, Universidad de Navarra, Avda, Pio XII, n 55, Pamplona 31008, Spain.
3: CIBERehd, Instituto de Salud Carlos III, Barcelona, Spain.
4: Department of Cell Death and Proliferation, Instituto de Investigaciones Biomédicas de Barcelona, CSIC and Liver Unit-Hospital Clinic-IDIBAPS, Barcelona, Spain.
5: Research Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles 90033, CA, USA.
6: Immunology and Immunotherapy Programme, CIMA, Idisna, Universidad de Navarra, Avda, Pio XII, n 55, Pamplona 31008, Spain.

Articles cited by this

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13

Liver regeneration. Hepatology (2006) 7.52

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem (2007) 4.42

Bile acids: regulation of synthesis. J Lipid Res (2009) 4.31

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science (2011) 3.16

Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem (2008) 3.08

Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut (2013) 3.08

The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A (2002) 2.93

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev (2012) 2.91

High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One (2011) 2.82

Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology (2011) 2.67

Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell (2003) 1.98

Growth hormone stimulates proliferation of old-aged regenerating liver through forkhead box m1b. Hepatology (2003) 1.94

Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int (2011) 1.92

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice. Hepatology (2014) 1.80

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology (2013) 1.78

Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology (2005) 1.76

Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci U S A (2001) 1.75

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discov (2015) 1.67

A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med (2014) 1.64

Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem (2002) 1.63

CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure. Gastroenterology (2015) 1.59

Aging and liver regeneration. Trends Endocrinol Metab (2009) 1.57

Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation (2003) 1.49

Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology (2005) 1.44

Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem (2012) 1.42

Mitogen-activated protein kinase-mediated disruption of enhancer-promoter communication inhibits hepatocyte nuclear factor 4alpha expression. Mol Cell Biol (2006) 1.37

Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology (2010) 1.29

Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol (2009) 1.28

Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc Natl Acad Sci U S A (2012) 1.22

Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology (2013) 1.17

The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration. Mol Cell Biol (2009) 1.17

Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol (2012) 1.10

The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation. Hepatology (2011) 1.07

Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun (2003) 1.03

Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex. J Biol Chem (2006) 1.03

Role of bile acids in liver injury and regeneration following acetaminophen overdose. Am J Pathol (2013) 0.99

Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice. Am J Physiol Gastrointest Liver Physiol (2008) 0.97

S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy. J Clin Invest (2011) 0.96

Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. Am J Pathol (2013) 0.96

Liver regeneration and aging: a current perspective. Curr Gerontol Geriatr Res (2011) 0.95

Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.93

Acute liver failure: A curable disease by 2024? J Hepatol (2015) 0.92

Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. Am J Pathol (2014) 0.92

Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. J Pharmacol Exp Ther (2010) 0.92

Advances in liver regeneration. Expert Rev Gastroenterol Hepatol (2014) 0.91

Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes. Gene Expr (2003) 0.88

Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. Cell Rep (2014) 0.88

Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice. Gut (2015) 0.87

Splicing regulator SLU7 is essential for maintaining liver homeostasis. J Clin Invest (2014) 0.86

The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int (2013) 0.84

Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer. Gene Expr (2015) 0.83

Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. J Gastroenterol (2013) 0.82

Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol (2016) 0.82

Reversal of hepatocyte senescence after continuous in vivo cell proliferation. Hepatology (2014) 0.81

Dysfunction of liver regeneration in aged liver after partial hepatectomy. J Gastroenterol Hepatol (2015) 0.81

Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy. Sci Rep (2015) 0.81

Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients. J Gastroenterol Hepatol (2014) 0.80

Impact of age on liver regeneration response to injury after partial hepatectomy in a rat model. J Surg Res (2011) 0.80

An Integrated Approach for the Identification of HNF4α-Centered Transcriptional Regulatory Networks During Early Liver Regeneration. Cell Physiol Biochem (2015) 0.80

Regulation of hepatocyte identity and quiescence. Cell Mol Life Sci (2015) 0.79

Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis. Dig Dis (2017) 0.78

Hepatostat: Liver regeneration and normal liver tissue maintenance. Hepatology (2017) 0.77

Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol (2016) 0.77

Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice. Hepatology (2016) 0.77

Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation. Hepatology (2016) 0.77

Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. Nat Commun (2017) 0.76

A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging. Age (Dordr) (2015) 0.76

HNF4α contributes to glucose formation in aged rat hepatocytes. Exp Gerontol (2013) 0.76

Dual Role of Epidermal Growth Factor Receptor in Liver Injury and Regeneration after Acetaminophen Overdose in Mice. Toxicol Sci (2016) 0.76

Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells. Hepatology (2016) 0.76

X-box Binding Protein 1 Regulates Unfolded Protein, Acute-phase, and DNA Damage Responses During Regeneration of Mouse Liver. Gastroenterology (2017) 0.76

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut (2017) 0.75

Non-alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community-based Polish survey. Liver Int (2017) 0.75

An integrated approach for the identification of USF1-centered transcriptional regulatory networks during liver regeneration. Biochim Biophys Acta (2014) 0.75

Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2. EMBO Mol Med (2016) 0.75

From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspective. F1000Res (2016) 0.75

STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver Damage. Front Immunol (2016) 0.75

Long distance calling for liver regeneration: identification of neuroendocrine signalling pathways activated after partial hepatectomy. J Hepatol (2010) 0.75

Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation. Transpl Int (2006) 0.75